These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2825591)

  • 1. Differential metabolism of (E)-5-(2-iodovinyl)-2'-deoxyuridine (IVDU) by equine herpesvirus type 1- and herpes simplex virus-infected cells.
    Kit S; Ichimura H; De Clercq E
    Antiviral Res; 1987 Aug; 8(1):41-51. PubMed ID: 2825591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective antiherpetic activity of carbocyclic analogues of (E)-5-(2-halogenovinyl)-2'-deoxyuridines: dependence on specific phosphorylation by viral thymidine kinase.
    De Clercq E; Balzarini J; Bernaerts R; Herdewijn P; Verbruggen A
    Biochem Biophys Res Commun; 1985 Jan; 126(1):397-403. PubMed ID: 2982373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of nucleoside analogs by equine herpesvirus type 1 pyrimidine deoxyribonucleoside kinase.
    Kit S; Ichimura H; De Clercq E
    Antiviral Res; 1987 Jan; 7(1):53-67. PubMed ID: 3026247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
    Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine and its carbocyclic analogue into DNA of herpes simplex virus type 1-infected cells in the antiviral effects of these compounds.
    Balzarini J; Bernaerts R; Verbruggen A; De Clercq E
    Mol Pharmacol; 1990 Mar; 37(3):402-7. PubMed ID: 2156154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of the carbocyclic analogue of (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells. Incorporation of C-IVDU into DNA.
    De Clercq E; Bernaerts R; Balzarini J; Herdewijn P; Verbruggen A
    J Biol Chem; 1985 Sep; 260(19):10621-8. PubMed ID: 2993282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    Balzarini J; de Clercq E; Ayusawa D; Seno T
    FEBS Lett; 1985 Jun; 185(1):95-100. PubMed ID: 2987041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative uptake studies of 131I-labeled (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells in vitro.
    Gill MJ; Samuel J; Wiebe LI; Knaus EE; Tyrrell DL
    Antimicrob Agents Chemother; 1984 Apr; 25(4):476-8. PubMed ID: 6732216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine into deoxyribonucleic acids of varicella-zoster virus (TK+ and TK- strains)-infected cells.
    Yokota T; Konno K; Shigeta S; Verbruggen A; De Clercq E
    Mol Pharmacol; 1987 May; 31(5):493-9. PubMed ID: 3033468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
    Balzarini J; De Clercq E; Baumgartner H; Bodenteich M; Griengl H
    Mol Pharmacol; 1990 Mar; 37(3):395-401. PubMed ID: 2156153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of arabinosylthymine in herpesviral replication: mechanism of action in vivo and in vitro.
    Aswell JF; Allen GP; Jamieson AT; Campbell DE; Gentry GA
    Antimicrob Agents Chemother; 1977 Aug; 12(2):243-54. PubMed ID: 197886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and cellular uptake of 2'-substituted analogues of (E)-5-(2-[125I]iodovinyl)-2'-deoxyuridine in tumor cells transduced with the herpes simplex type-1 thymidine kinase gene. Evaluation as probes for monitoring gene therapy.
    Morin KW; Atrazheva ED; Knaus EE; Wiebe LI
    J Med Chem; 1997 Jul; 40(14):2184-90. PubMed ID: 9216837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of thymidine kinase activities indiced in cells productively infected with herpesvirus saimiri and herpes simplex virus.
    Honess RW; O'Hare P; Young D
    J Gen Virol; 1982 Feb; 58(Pt 2):237-49. PubMed ID: 6278057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of equine herpesvirus type 1 subtype 1-induced ribonucleotide reductase by the nonapeptide YAGAVVNDL.
    Telford E; Lankinen H; Marsden H
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1373-8. PubMed ID: 2161904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased sensitivity of thymidine kinase-deficient (TK-) tumor cell lines to the cell growth inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds.
    Balzarini J; De Clercq E; Verbruggen A; Crumpacker C; Ayusawa D; Seno T
    Anticancer Res; 1986; 6(5):1077-84. PubMed ID: 2432829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific phosphorylation of E-5-(2-iodovinyl)-2'-deoxyuridine by herpes simplex virus-infected cells.
    Descamps J; De Clercq E
    J Biol Chem; 1981 Jun; 256(12):5973-6. PubMed ID: 6263899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (E)-5-(2-bromovinyl)uridine requires phosphorylation by the herpes simplex virus (type 1)-induced thymidine kinase to express its antiviral activity.
    Bernaerts R; Desgranges C; De Clercq E
    Biochem Pharmacol; 1989 Jun; 38(12):1955-61. PubMed ID: 2545207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential phosphorylation of (E)-5-(2-bromovinyl)-2'-deoxyuridine monophosphate by thymidylate kinases from herpes simplex viruses types 1 and 2 and varicella zoster virus.
    Fyfe JA
    Mol Pharmacol; 1982 Mar; 21(2):432-7. PubMed ID: 6285172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential binding affinities of sugar-modified derivatives of (E)-5-(2-bromovinyl)-2'-deoxyuridine for herpes simplex virus-induced and human cellular deoxythymidine kinases.
    Zou FC; Dutschman GE; De Clercq E; Cheng YC
    Biochem Pharmacol; 1984 Jun; 33(11):1797-800. PubMed ID: 6329218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.